The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of camrelizumab combined with chemotherapy versus chemotherapy alone as preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma: Preliminary results from a multicenter, prospective, randomized controlled study.
 
Renquan Zhang
No Relationships to Disclose
 
De sheng Song
No Relationships to Disclose
 
Wei Liu
No Relationships to Disclose
 
Long Yao
No Relationships to Disclose
 
An guo Chen
No Relationships to Disclose
 
Wei Ge
No Relationships to Disclose
 
Shao hui Hu
No Relationships to Disclose
 
Jian Chen
No Relationships to Disclose
 
Yun long Huang
No Relationships to Disclose
 
Jun rui Xun
No Relationships to Disclose